Meshinchi S - Search Results

1

Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Gerbing RB, Wang YC, Ries RE, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB. Laszlo GS, et al. Among authors: meshinchi s. Clin Cancer Res. 2015 Jul 15;21(14):3187-95. doi: 10.1158/1078-0432.CCR-14-2684. Epub 2015 Mar 30. Clin Cancer Res. 2015. PMID: 25825478 Free PMC article.

2

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK, Bernstein ID, Radich JP. Meshinchi S, et al. Blood. 2001 Jan 1;97(1):89-94. doi: 10.1182/blood.v97.1.89. Blood. 2001. PMID: 11133746 Free article.

3

Molecular targets in acute myelogenous leukemia.

Stirewalt DL, Meshinchi S, Radich JP. Stirewalt DL, et al. Among authors: meshinchi s. Blood Rev. 2003 Mar;17(1):15-23. doi: 10.1016/s0268-960x(02)00057-7. Blood Rev. 2003. PMID: 12490207 Review.

4

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

Meshinchi S, Stirewalt DL, Alonzo TA, Zhang Q, Sweetser DA, Woods WG, Bernstein ID, Arceci RJ, Radich JP. Meshinchi S, et al. Blood. 2003 Aug 15;102(4):1474-9. doi: 10.1182/blood-2003-01-0137. Epub 2003 Apr 17. Blood. 2003. PMID: 12702504 Free article.

5

Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.

Meshinchi S, Smith FO, Arceci RJ. Meshinchi S, et al. Curr Oncol Rep. 2003 Nov;5(6):489-97. doi: 10.1007/s11912-003-0010-1. Curr Oncol Rep. 2003. PMID: 14521808 Review.

6

Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.

Meshinchi S, Leisenring WM, Carpenter PA, Woolfrey AE, Sievers EL, Radich JP, Sanders JE. Meshinchi S, et al. Biol Blood Marrow Transplant. 2003 Nov;9(11):706-13. doi: 10.1016/j.bbmt.2003.08.003. Biol Blood Marrow Transplant. 2003. PMID: 14652854 Free article.

7

Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition.

Brown P, Meshinchi S, Levis M, Alonzo TA, Gerbing R, Lange B, Arceci R, Small D. Brown P, et al. Among authors: meshinchi s. Blood. 2004 Sep 15;104(6):1841-9. doi: 10.1182/blood-2004-03-1034. Epub 2004 May 27. Blood. 2004. PMID: 15166029 Free article.

8

Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.

Tse W, Meshinchi S, Alonzo TA, Stirewalt DL, Gerbing RB, Woods WG, Appelbaum FR, Radich JP. Tse W, et al. Among authors: meshinchi s. Blood. 2004 Nov 15;104(10):3058-63. doi: 10.1182/blood-2003-12-4347. Epub 2004 Jun 24. Blood. 2004. PMID: 15217837 Free article. Clinical Trial.

9

PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.

Loh ML, Reynolds MG, Vattikuti S, Gerbing RB, Alonzo TA, Carlson E, Cheng JW, Lee CM, Lange BJ, Meshinchi S; Children's Cancer Group. Loh ML, et al. Among authors: meshinchi s. Leukemia. 2004 Nov;18(11):1831-4. doi: 10.1038/sj.leu.2403492. Leukemia. 2004. PMID: 15385933

10

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group.

Children's Oncology Group; Aplenc R, Alonzo TA, Gerbing RB, Smith FO, Meshinchi S, Ross JA, Perentesis J, Woods WG, Lange BJ, Davies SM. Children's Oncology Group, et al. Among authors: meshinchi s. Blood. 2006 Jul 1;108(1):74-80. doi: 10.1182/blood-2005-10-4004. Epub 2006 Mar 14. Blood. 2006. PMID: 16537811 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters